In this randomised , double-blind , placebo-controlled , exploratory , proof-of-concept phase @ trial , patients aged @-@ years with five to @ migraine days per @-day period were randomly assigned ( @:@ ) via an interactive web response system to receive an intravenous dose of ALD@ @ mg or placebo .